NexCure, Inc.

About NexCure, Inc.

NexCure is dedicated to expanding access to advanced therapeutics by partnering with health systems to build and operate outpatient treatment centers. Their mission is to deliver world-class cancer care, focusing on CAR-T and T-cell engager therapies, with greater efficiency and convenience, bringing treatment closer to home for patients.

Products & Services

Outpatient Treatment Centers:NexCure builds and operates innovative centers across the country to provide CAR-T and other advanced therapies in compassionate, outpatient settings.

AI-Powered Platform:Integrates AI for patient selection, remote monitoring, and standardized clinical protocols to ensure safe, personalized treatment.

Specialties

CAR-T Therapy T-Cell Engagers Outpatient Cancer Care AI-Powered Patient Selection Remote Monitoring Standardized Clinical Protocols

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 19000000 MR: - FA: 19 million FAN: 19000000	D: 2026-03-05 FD: 2026-03-05	3 investors

Series A Latest

2026-03-05

$19.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jennifer Smith

CEO & Board Member

S

Sophie Papa

Founder & CMO

A

Anish More

Founder & CBO

P

Paul Rothman

Founder & Board Chair

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

NexCure, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised